A $100 Billion Opportunity Just Getting Started скачать в хорошем качестве

A $100 Billion Opportunity Just Getting Started

The cure for cancer - at least today - is early detection. That's because if you can detect cancer soon enough, the chance for survival increases dramatically. We've identified two pure-play companies using blood tests for cancer detection, what's known as "liquid biopsy." Those companies are Guardant Health $GH and GRAIL $GRAL. Both offer a "multi-cancer" test, meaning you can screen for multiple cancers with a single blood sample. The market opportunity is measured in the hundreds of billions of dollars. Can these companies succeed where Theranos failed? RESEARCH PIECES USED IN THIS VIDEO: 1. The Massive Cancer Blood Test Opportunity https://www.nanalyze.com/2025/01/the-... 2. Guide to Biotech Investing    • The Only Guide to Biotech Investing You'll...   CHAPTERS: 00:00 Intro 01:13 The multi-cancer screening opportunity 02:49 The low-hanging fruit in cancer screening 04:04 The problem with cancer screening today 04:30 GRAIL's Galleri test 07:35 Cancer testing market 09:58 Guardant Health liquid biopsy 12:17 Other cancer testing players 16:53 Conclusion ABOUT US: This video is brought to you by Nanalyze, a media and research firm founded by finance professionals with decades of experience. We share insights about #DisruptiveTechnology #stocks in a language that is future-proof and easy to understand. Read all the Nanalyze Premium articles you'd like for free! Sign up for a 30-day trial of our monthly subscription with no strings attached: https://www.nanalyze.com/subscription... DISCLAIMER: Our content is intended to be used and must be used for informational purposes only. It is very important to do your own analysis before making any investment based on your own personal circumstances. You should take independent financial advice from a professional in connection with, along with independently researching and verifying, any information contained within our YouTube videos or on our website, whether for the purpose of making an investment or otherwise. #cancer #cancertesting #biotechstocks #biotechinvesting